DBV Technologies SA (DBVT)

18.57 +0.03 (+0.16%) USD  |  NASDAQ  |  May 21, 16:00
18.60 +0.03 (+0.16%) After-Hours: 19:59
More

DBV Technologies Research and Development Expense (TTM) : 119.79M for March 31, 2026

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for DBVT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Cellectis SA 80.74M
Akari Therapeutics Plc 3.464M
Biodexa Pharmaceuticals Plc 5.234M
NuCana Plc 19.05M
Mereo BioPharma Group Plc 18.61M